MedPath

Prospective assessment of swallowing and speech function 10 years after preventive swallowing rehabilitation and chemoradiotherapy for head and neck cancer

Completed
Conditions
Functionele beperkingen op het gebied van slikken en spreken.
Swallowing and speech impairment
Registration Number
NL-OMON44230
Lead Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
22
Inclusion Criteria

Evaluable and disease-free head and neck cancer survivors who participated in the randomized controlled trial regarding a preventive rehabilitation program during chemoradiotherapy, performed ten years ago.

Exclusion Criteria

(suspected) recurrent head and neck cancer

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>- Objective swallowing outcomes<br /><br>o Videofluoroscopy<br /><br>o Other parameters: tube dependency/nutritional supplements, Functional Oral<br /><br>Intake Scale (FOIS), weight change/BMI, maximal inter-incisal opening (MIO),<br /><br>symptom specific questions, pain (VAS)<br /><br>- Objective speech outcomes<br /><br>o Speech recordings<br /><br>- Subjective outcomes<br /><br>o SWAL-QOL<br /><br>o Voice Handicap Index<br /><br>o Speech Handicap Index<br /><br>o EORTC QLQ-C30 and H&N35<br /><br>o EQ-5D-5L<br /><br>o Study specific questions </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Not applicable</p><br>
© Copyright 2025. All Rights Reserved by MedPath